Vanguard Group Inc Puma Biotechnology, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,636,191 shares of PBYI stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,636,191
Previous 3,598,973 1.03%
Holding current value
$11.7 Million
Previous $11.7 Million 20.97%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$2.25 - $4.03 $83,740 - $149,988
37,218 Added 1.03%
3,636,191 $9.27 Million
Q2 2024

Aug 13, 2024
BUY
$2.92 - $5.83 $314,554 - $628,030
107,724 Added 3.09%
3,598,973 $11.7 Million
Q1 2024

May 10, 2024
SELL
$4.29 - $7.4 $1.33 Million - $2.3 Million
-310,832 Reduced 8.18%
3,491,249 $18.5 Million
Q4 2023

Feb 14, 2024
BUY
$2.23 - $4.49 $66,204 - $133,299
29,688 Added 0.79%
3,802,081 $16.5 Million
Q3 2023

Nov 14, 2023
BUY
$2.63 - $4.09 $21,729 - $33,791
8,262 Added 0.22%
3,772,393 $9.92 Million
Q2 2023

Aug 14, 2023
SELL
$2.6 - $3.58 $18,756 - $25,826
-7,214 Reduced 0.19%
3,764,131 $13.3 Million
Q1 2023

May 15, 2023
BUY
$2.21 - $4.82 $403,154 - $879,278
182,423 Added 5.08%
3,771,345 $11.7 Million
Q4 2022

Feb 10, 2023
SELL
$2.12 - $5.08 $73,578 - $176,311
-34,707 Reduced 0.96%
3,588,922 $15.2 Million
Q3 2022

Nov 14, 2022
SELL
$2.27 - $3.84 $17,706 - $29,952
-7,800 Reduced 0.21%
3,623,629 $8.59 Million
Q2 2022

Aug 12, 2022
BUY
$1.64 - $3.3 $269,925 - $543,143
164,589 Added 4.75%
3,631,429 $10.3 Million
Q1 2022

May 13, 2022
SELL
$2.13 - $3.24 $454,429 - $691,244
-213,347 Reduced 5.8%
3,466,840 $9.99 Million
Q4 2021

Feb 14, 2022
BUY
$2.85 - $6.58 $144,648 - $333,961
50,754 Added 1.4%
3,680,187 $11.2 Million
Q3 2021

Nov 12, 2021
BUY
$6.63 - $9.39 $287,675 - $407,432
43,390 Added 1.21%
3,629,433 $25.4 Million
Q2 2021

Aug 13, 2021
BUY
$8.98 - $11.6 $32.2 Million - $41.6 Million
3,586,043 New
3,586,043 $32.9 Million

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
29M
Call Options Held
50.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $146M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email